These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 19850989

  • 1. Hormone replacement therapy and the increase in the incidence of invasive lobular cancer.
    Ravdin PM.
    Breast Dis; ; 30():3-8. PubMed ID: 19850989
    [Abstract] [Full Text] [Related]

  • 2. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
    Zanetti-Dällenbach RA, Krause EM, Lapaire O, Gueth U, Holzgreve W, Wight E.
    Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, Magnusson C.
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma.
    Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Coates RJ, Marchbanks PA, Norman SA, Weiss LK, Ursin G, Berlin JA, Burkman RT, Deapen D, Folger SG, McDonald JA, Simon MS, Strom BL, Wingo PA, Spirtas R.
    Cancer; 2002 Dec 15; 95(12):2455-64. PubMed ID: 12467057
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study.
    Tjønneland A, Christensen J, Thomsen BL, Olsen A, Overvad K, Ewertz M, Mellemkjaer L.
    Cancer; 2004 Jun 01; 100(11):2328-37. PubMed ID: 15160335
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study.
    Rosenberg LU, Magnusson C, Lindström E, Wedrén S, Hall P, Dickman PW.
    Breast Cancer Res; 2006 Jun 01; 8(1):R11. PubMed ID: 16507159
    [Abstract] [Full Text] [Related]

  • 15. Evidence from randomised trials on the long-term effects of hormone replacement therapy.
    Beral V, Banks E, Reeves G.
    Lancet; 2002 Sep 21; 360(9337):942-4. PubMed ID: 12354487
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hormone replacement therapy and breast cancer risk in California.
    Coombs NJ, Taylor R, Wilcken N, Fiorica J, Boyages J.
    Breast J; 2005 Sep 21; 11(6):410-5. PubMed ID: 16297085
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA, Blake JM, Crosignani PG.
    Hum Reprod Update; 2005 Sep 21; 11(6):545-60. PubMed ID: 16150813
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.